Heidi McNally

• Endomagnetics on its acquisition by Hologic for approximately $310 million
• OKRA.ai on its acquisition by Envision Pharma Group
• SynAffix and its selling shareholders on the sale of SynAffix to Lonza for €100 million, with up to an addition €60 million in contingent payments
• Syndesi Therapeutics and its selling shareholders on Syndesi’s acquisition by AbbVie for up to $1 billion
• Nordic Capital on the €2.143 billion sale of Itiviti to NYSE listed Broadridge Financial Solutions, Inc.*
• Judges Scientific plc on the acquisition of Heath Scientific Company Ltd (trading as Thermal Hazard Technology)*
• ArchiMed on the acquisition of Direct Healthcare Group from NorthEdge Capital*
• Welsh, Carson, Anderson & Stowe on the sale of its portfolio business AIM Software to SimCorp for an enterprise value of €60 million*
• One Equity Partners on the acquisition of the MERA group*

*Denotes experience prior to joining Goodwin.

• Maxion Therapeutics on its $72 million Series A financing round led by General Catalyst
• Rhizocore on raising a £4.5 million investment round led by The First Thirty
• UB FIGG on its lead growth investment into UK-based Notpla, a family of regenerative packaging materials made from seaweed and plants
• Felicis on its lead investment in the $27.5 million Series A financing round of Sona Technologies
• Material Impact and Dr. Martens on their investment as part of an $18 million financing round for ELeather, now rebranded as Gen Phoenix
• Balderton Capital on its lead investment in TreasurySpring’s £23 million Series B financing round
• Boehringer Ingelheim Venture Fund, Novo Holdings and Evotec on co-leading a £24 million Series A investment in Centauri Therapeutics
• Omega Funds on co-leading Artios Pharma’s $153 million Series C financing

*Denotes experience prior to joining Goodwin.